New funding from Breast Cancer Now supports research on treatment-resistant ER-positive breast cancer

Researchers are investigating how the most common type of breast cancer resists hormone therapy, thanks to new funding from Breast Cancer Now.

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s surprising rise

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale. Gilead needs Arcellx more than ever

January 25, 2024

New study reveals increased cancer risk linked to higher BMI in adults with cardiovascular diseases

The joint and individual correlations of CVD/T2D and BMI with cancer risk.

November 23, 2023

Robotics Partnership Aims to Democratize Microbiome Analysis

A car in every garage. A chicken in every pot. A robotics platform for every microbiome. That is the thinking behind a new partnership announced

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.